Title:
【発明の名称】神経防護性の3-(ピペリジニル-1)-クロマン-4,7-ジオールおよび1-(4-ヒドロフェニル)-2-(ピペリジニル-1)-アルカノール誘導体
Document Type and Number:
Japanese Patent JP2888988
Kind Code:
B2
Abstract:
PCT No. PCT/IB95/00380 Sec. 371 Date Feb. 13, 1996 Sec. 102(e) Date Feb. 13, 1996 PCT Filed May 18, 1995 PCT Pub. No. WO96/06081 PCT Pub. Date Feb. 29, 1996This invention relates to compounds of formula (I), or pharmaceutically acceptable acid addition salts thereof, wherein: (a) R2 and R5 are taken separately and R1, R2, R3 and R4 are each independently hydrogen, (C1-C6) alkyl, halo, CF3, OH or OR7 and R5 is methyl or ethyl; or (b) R2 and R5 are taken together, forming a chroman-4-ol ring, and R1, R3 and R4 are each independently hydrogen, (C1-C6) alkyl, halo, CF3, OH or OR7; and R6 is a substituted piperidinyl, pyrrolidinyl or 8-azabicyclo(3.2.1)octanyl derivative; provided that (a) when R2 and R5 are taken separately, at least one of R1, R2, R3 and R4 is not hydrogen; and (b) when R2 and R5 are taken together, at least one of R1, R3 and R4 is not hydrogen; pharmaceutical compositions thereof; and methods of treating mammals suffering from stroke, spinal cord trauma, traumatic brain injury, multiinfarct dementia, CNS degenerative diseases such as Alzheimer's disease, senile dementia of the Alzheimer's type, Huntington's disease, Parkinson's disease, epilepsy, amyotrophic lateral sclerosis, pain, AIDS dementia, psychotic conditions, drug addictions, migraine, hypoglycemia, anxiolytic conditions, urinary incontinence and an ischemic event arising from CNS surgery, open heart surgery or any procedure during which the function of the cardiovascular system is compromised with a compound of formula (I) hereinabove or a pharmaceutically acceptable salt thereof.
Inventors:
CHENAADO BAATORANDO ERU
BATORAA TOTSUDO DABURYUU
BATORAA TOTSUDO DABURYUU
Application Number:
JP50789596A
Publication Date:
May 10, 1999
Filing Date:
May 18, 1995
Export Citation:
Assignee:
FUAIZAA INC
International Classes:
A61K31/40; A61K31/443; A61K31/445; A61K31/451; A61K31/452; A61K31/4523; A61P9/10; A61P25/00; A61P25/04; A61P25/08; A61P25/28; C07D207/12; C07D211/52; C07D405/04; C07D405/14; C07D451/02; C07D451/04; C07D451/06; C07D453/02; (IPC1-7): C07D211/52; C07D405/04; C07D453/02
Attorney, Agent or Firm:
Kazuo Shamoto (4 outside)